{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["aptamer", "regenerative medicine", "repair of tissue injury", "tissue regeneration", "transformation and application"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36105606", "DateRevised": {"Year": "2022", "Month": "09", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "29"}], "Language": ["eng"], "ELocationID": ["976960", "10.3389/fbioe.2022.976960"], "Journal": {"ISSN": "2296-4185", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in bioengineering and biotechnology", "ISOAbbreviation": "Front Bioeng Biotechnol"}, "ArticleTitle": "Application of aptamers in regenerative medicine.", "Pagination": {"StartPage": "976960", "MedlinePgn": "976960"}, "Abstract": {"AbstractText": ["Regenerative medicine is a discipline that studies how to use biological and engineering principles and operation methods to repair and regenerate damaged tissues and organs. Until now, regenerative medicine has focused mainly on the in-depth study of the pathological mechanism of diseases, the further development and application of new drugs, and tissue engineering technology strategies. The emergence of aptamers has supplemented the development methods and types of new drugs and enriched the application elements of tissue engineering technology, injecting new vitality into regenerative medicine. The role and application status of aptamers screened in recent years in various tissue regeneration and repair are reviewed, and the prospects and challenges of aptamer technology are discussed, providing a basis for the design and application of aptamers in long-term transformation."], "CopyrightInformation": "Copyright \u00a9 2022 Luo, Chen, Zhou, Wang, Li, Liu, Tang and Wang."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Youjiang Medical University for Nationalities, Baise, Guangxi, China."}, {"Identifier": [], "Affiliation": "Guangxi Key Laboratory of basic and translational research of Bone and Joint Degenerative Diseases, Guangxi Biomedical Materials Engineering Research Center for Bone and Joint Degenerative Diseases, Department of Orthopedics, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China."}], "LastName": "Luo", "ForeName": "Zhaohui", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Botanical Garden of Medicinal Plants, Nanning, China."}, {"Identifier": [], "Affiliation": "Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China."}], "LastName": "Chen", "ForeName": "Shimin", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Youjiang Medical University for Nationalities, Baise, Guangxi, China."}], "LastName": "Zhou", "ForeName": "Jing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Mechanical Engineering, Dongguan University of Technology, Dongguan, Guangdong, China."}], "LastName": "Wang", "ForeName": "Chong", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Academy of Orthopedics, Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China."}], "LastName": "Li", "ForeName": "Kai", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of basic and translational research of Bone and Joint Degenerative Diseases, Guangxi Biomedical Materials Engineering Research Center for Bone and Joint Degenerative Diseases, Department of Orthopedics, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China."}], "LastName": "Liu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guangxi Key Laboratory of basic and translational research of Bone and Joint Degenerative Diseases, Guangxi Biomedical Materials Engineering Research Center for Bone and Joint Degenerative Diseases, Department of Orthopedics, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi, China."}], "LastName": "Tang", "ForeName": "Yujin", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Metal Matrix Composites, School of Material Science and Engineering, Shanghai Jiao Tong University, Shanghai, China."}], "LastName": "Wang", "ForeName": "Liqiang", "Initials": "L"}], "PublicationTypeList": ["Systematic Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Bioeng Biotechnol", "NlmUniqueID": "101632513", "ISSNLinking": "2296-4185"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abune L., Zhao N., Lai J., Peterson B., Szczesny S., Wang Y. (2019). Macroporous hydrogels for stable sequestration and sustained release of vascular endothelial growth factor and basic fibroblast growth factor using nucleic acid aptamers. ACS Biomater. Sci. Eng. 5 (5), 2382\u20132390. 10.1021/acsbiomaterials.9b00423", "ArticleIdList": ["10.1021/acsbiomaterials.9b00423", "PMC6900755", "31819896"]}, {"Citation": "Agrawal N. K., Allen P., Song Y. H., Wachs R. A., Du Y., Ellington A. D., et al. (2020). Oligonucleotide-functionalized hydrogels for sustained release of small molecule (aptamer) therapeutics. Acta Biomater. 102, 315\u2013325. 10.1016/j.actbio.2019.11.037", "ArticleIdList": ["10.1016/j.actbio.2019.11.037", "31760222"]}, {"Citation": "Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M. J. A. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29 (4), 341\u2013345. 10.1038/nbt.1807", "ArticleIdList": ["10.1038/nbt.1807", "21423189"]}, {"Citation": "Andreas K., Sittinger M., Ringe J. (2014). Toward in situ tissue engineering: Chemokine-guided stem cell recruitment. Trends Biotechnol. 32 (9), 483\u2013492. 10.1016/j.tibtech.2014.06.008", "ArticleIdList": ["10.1016/j.tibtech.2014.06.008", "25059433"]}, {"Citation": "Ardjomandi N., Niederlaender J., Aicher W. K., Reinert S., Schweizer E., Wendel H.-P., et al. (2013). Identification of an aptamer binding to human osteogenic-induced progenitor cells. Nucleic Acid. Ther. 23 (1), 44\u201361. 10.1089/nat.2012.0349", "ArticleIdList": ["10.1089/nat.2012.0349", "PMC3696924", "23289534"]}, {"Citation": "Atala A., Forgacs G. (2019). Three-dimensional bioprinting in regenerative medicine: Reality, hype, and future. Stem Cells Transl. Med. 8 (8), 744\u2013745. 10.1002/sctm.19-0089", "ArticleIdList": ["10.1002/sctm.19-0089", "PMC6646681", "31058436"]}, {"Citation": "Bieber A. J., Warrington A., Asakura K., Ciric B., Kaveri S. V., Pease L. R., et al. (2002). Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia 37 (3), 241\u2013249. 10.1002/glia.10033", "ArticleIdList": ["10.1002/glia.10033", "11857682"]}, {"Citation": "Bose P. (2021). Central pontine myelinolysis and the osmotic demyelination syndromes: An open and shut case? Acta Neurol. Belg 121 (4), 849\u2013858. 10.1007/s13760-021-01634-0", "ArticleIdList": ["10.1007/s13760-021-01634-0", "33713026"]}, {"Citation": "Boshtam M., Asgary S., Kouhpayeh S., Shariati L., Khanahmad H. (2017). Aptamers against pro- and anti-inflammatory cytokines: A review. Inflammation 40 (1), 340\u2013349. 10.1007/s10753-016-0477-1", "ArticleIdList": ["10.1007/s10753-016-0477-1", "27878687"]}, {"Citation": "Burr\u00e9 J., Sharma M., S\u00fcdhof T. C. (2018). Cell biology and pathophysiology of \u03b1-synuclein. Cold Spring Harb. Perspect. Med. 8 (3). 10.1101/cshperspect.a024091", "ArticleIdList": ["10.1101/cshperspect.a024091", "PMC5519445", "28108534"]}, {"Citation": "Byun J. (2021). Recent progress and opportunities for nucleic acid aptamers. Life (Basel) 11 (3). 10.3390/life11030193", "ArticleIdList": ["10.3390/life11030193", "PMC7997341", "33671039"]}, {"Citation": "Cai S., Yan J., Xiong H., Liu Y., Peng D., Liu Z. (2018). Investigations on the interface of nucleic acid aptamers and binding targets. Analyst 143 (22), 5317\u20135338. 10.1039/c8an01467a", "ArticleIdList": ["10.1039/c8an01467a", "30357118"]}, {"Citation": "Cao J., Su J., An M., Yang Y., Zhang Y., Zuo J., et al. (2021). Novel DEK-targeting aptamer delivered by a hydrogel microneedle attenuates collagen-induced arthritis. Mol. Pharm. 18 (1), 305\u2013316. 10.1021/acs.molpharmaceut.0c00954", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c00954", "33253580"]}, {"Citation": "de Melo M., da Silva Cunha S. C. P., de Miranda M. C., Barbosa J. L., Faria J. A. Q. A., Rodrigues M. A., et al. (2021). Selection of DNA aptamers for differentiation of human adipose-derived mesenchymal stem cells from fibroblasts. Appl. Biochem. Biotechnol. 193 (11), 3704\u20133718. 10.1007/s12010-021-03618-5", "ArticleIdList": ["10.1007/s12010-021-03618-5", "34363139"]}, {"Citation": "Dubik M., Marczynska J., M\u00f8rch M. T., Webster G., Jensen K. N., Wlodarczyk A., et al. (2021). Innate signaling in the CNS prevents demyelination in a focal EAE model. Front. Neurosci. 15, 682451. 10.3389/fnins.2021.682451", "ArticleIdList": ["10.3389/fnins.2021.682451", "PMC8209300", "34149350"]}, {"Citation": "Durand M. (2021). Large-scale simulations of biological cell sorting driven by differential adhesion follow diffusion-limited domain coalescence regime. PLoS Comput. Biol. 17 (8), e1008576. 10.1371/journal.pcbi.1008576", "ArticleIdList": ["10.1371/journal.pcbi.1008576", "PMC8389523", "34398883"]}, {"Citation": "Edgar L., Pu T., Porter B., Aziz J. M., La Pointe C., Asthana A., et al. (2020). Regenerative medicine, organ bioengineering and transplantation. Br. J. Surg. 107 (7), 793\u2013800. 10.1002/bjs.11686", "ArticleIdList": ["10.1002/bjs.11686", "32463143"]}, {"Citation": "Enam S. F., Krieger J. R., Saxena T., Watts B. E., Olingy C. E., Botchwey E. A., et al. (2017). Enrichment of endogenous fractalkine and anti-inflammatory cells via aptamer-functionalized hydrogels. Biomaterials 142, 52\u201361. 10.1016/j.biomaterials.2017.07.013", "ArticleIdList": ["10.1016/j.biomaterials.2017.07.013", "28727998"]}, {"Citation": "Fereidan-Esfahani M., Yue W. Y., Wilbanks B., Johnson A. J., Warrington A. E., Howe C. L., et al. (2020). Remyelination-promoting DNA aptamer conjugate myaptavin-3064 binds to adult oligodendrocytes in vitro . Pharm. (Basel) 13 (11). 10.3390/ph13110403", "ArticleIdList": ["10.3390/ph13110403", "PMC7699424", "33228043"]}, {"Citation": "Fu X. (2018). Regenerative medicine in China: New advances and hopes. Sci. China Life Sci. 61 (10), 1135\u20131136. 10.1007/s11427-018-9394-9", "ArticleIdList": ["10.1007/s11427-018-9394-9", "30264197"]}, {"Citation": "Gao Y., Chen X., Tian T. (2022). A lysosome-activated tetrahedral nanobox for encapsulated siRNA delivery[J]. Adv. Mater 2022, e2201731.", "ArticleIdList": ["35511782"]}, {"Citation": "Gong Z., Xia K., Xu A., Yu C., Wang C., Zhu J., et al. (2020). Stem cell transplantation: A promising therapy for spinal cord injury. Cscr 15 (4), 321\u2013331. 10.2174/1574888x14666190823144424", "ArticleIdList": ["10.2174/1574888x14666190823144424", "31441733"]}, {"Citation": "Goverman J. (2009). Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9 (6), 393\u2013407. 10.1038/nri2550", "ArticleIdList": ["10.1038/nri2550", "PMC2813731", "19444307"]}, {"Citation": "Guo K. T., Sch\u00c4fer R., Paul A., Gerber A., Ziemer G., Wendel H. P. (2006). A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high\u2010specific DNA aptamers. Stem Cells 24 (10), 2220\u20132231. 10.1634/stemcells.2006-0015", "ArticleIdList": ["10.1634/stemcells.2006-0015", "16794266"]}, {"Citation": "Guo K. T., Scharnweber D., Schwenzer B., Ziemer G., Wendel H. P. (2007). The effect of electrochemical functionalization of Ti-alloy surfaces by aptamer-based capture molecules on cell adhesion. Biomaterials 28 (3), 468\u2013474. 10.1016/j.biomaterials.2006.09.021", "ArticleIdList": ["10.1016/j.biomaterials.2006.09.021", "17045642"]}, {"Citation": "Guo K., Wendel H. P., Scheideler L., Ziemer G., Scheule A. M. (2005). Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion. J. Cell. Mol. Med. 9 (3), 731\u2013736. 10.1111/j.1582-4934.2005.tb00503.x", "ArticleIdList": ["10.1111/j.1582-4934.2005.tb00503.x", "PMC6741414", "16202220"]}, {"Citation": "Haller C., Sobolewska B., Schibilsky D., Avci-Adali M., Schlensak C., Wendel H.-P., et al. (2015). One-staged aptamer-based isolation and application of endothelial progenitor cells in a porcine myocardial infarction model. Nucleic Acid. Ther. 25 (1), 20\u201326. 10.1089/nat.2014.0499", "ArticleIdList": ["10.1089/nat.2014.0499", "25494449"]}, {"Citation": "Heider R. M., Smestad J. A., Lemus H. N., Wilbanks B., Warrington A. E., Peters J. P., et al. (2018). An assay that predicts in vivo efficacy for DNA aptamers that stimulate remyelination in a mouse model of multiple sclerosis. Mol. Ther. - Methods & Clin. Dev. 9, 270\u2013277. 10.1016/j.omtm.2018.03.005", "ArticleIdList": ["10.1016/j.omtm.2018.03.005", "PMC5918178", "29707601"]}, {"Citation": "Hoehlig K., Maasch C., Shushakova N., Buchner K., Huber-Lang M., Purschke W. G., et al. (2013). A novel C5a-neutralizing mirror-image (l-)Aptamer prevents organ failure and improves survival in experimental sepsis. Mol. Ther. 21 (12), 2236\u20132246. 10.1038/mt.2013.178", "ArticleIdList": ["10.1038/mt.2013.178", "PMC3863792", "23887360"]}, {"Citation": "Hoffmann J., Paul A., Harwardt M., Groll J., Reeswinkel T., Klee D., et al. (2008). Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J. Biomed. Mat. Res. 84A (3), 614\u2013621. 10.1002/jbm.a.31309", "ArticleIdList": ["10.1002/jbm.a.31309", "17635015"]}, {"Citation": "Hosseini S. F., Alibolandi M., Rafatpanah H. (2019). Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score[J]. J. Control Release 299, 149\u2013164.", "ArticleIdList": ["30807806"]}, {"Citation": "Hou Z., Meyer S., Propson N. E., Nie J., Jiang P., Stewart R., et al. (2015). Characterization and target identification of a DNA aptamer that labels pluripotent stem cells. Cell Res. 25 (3), 390\u2013393. 10.1038/cr.2015.7", "ArticleIdList": ["10.1038/cr.2015.7", "PMC4349250", "25591927"]}, {"Citation": "Hu X., Wang Y., Tan Y., Wang J., Liu H., Wang Y., et al. (2017). A difunctional regeneration scaffold for knee repair based on aptamer-directed cell recruitment. Adv. Mater 29 (15). 10.1002/adma.201605235", "ArticleIdList": ["10.1002/adma.201605235", "28185322"]}, {"Citation": "Iwagawa T., Ohuchi S. P., Watanabe S., Nakamura Y. (2012). Selection of RNA aptamers against mouse embryonic stem cells. Biochimie 94 (1), 250\u2013257. 10.1016/j.biochi.2011.10.017", "ArticleIdList": ["10.1016/j.biochi.2011.10.017", "22085640"]}, {"Citation": "James B. D., Allen J. B. (2021). Self-assembled VEGF-R2 targeting DNA aptamer-collagen fibers stimulate an angiogenic-like endothelial cell phenotype. Mater. Sci. Eng. C 120, 111683. 10.1016/j.msec.2020.111683", "ArticleIdList": ["10.1016/j.msec.2020.111683", "33545845"]}, {"Citation": "Juhl O. T., Zhao N., Merife A. B., Cohen D., Friedman M., Zhang Y., et al. (2019). Aptamer-functionalized fibrin hydrogel improves vascular endothelial growth factor release kinetics and enhances angiogenesis and osteogenesis in critically sized cranial defects. ACS Biomater. Sci. Eng. 5 (11), 6152\u20136160. 10.1021/acsbiomaterials.9b01175", "ArticleIdList": ["10.1021/acsbiomaterials.9b01175", "PMC7079287", "32190730"]}, {"Citation": "Kapoor R., Ho P. R., Campbell N., Chang I., Deykin A., Forrestal F., et al. (2018). Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): A phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension. Lancet Neurol. 17 (5), 405\u2013415. 10.1016/S1474-4422(18)30069-3", "ArticleIdList": ["10.1016/S1474-4422(18)30069-3", "29545067"]}, {"Citation": "Kim D. H., Ahn J., Kang H. K., Kim M.-S., Kim N.-G., Kook M. G., et al. (2021). Development of highly functional bioengineered human liver with perfusable vasculature. Biomaterials 265, 120417. 10.1016/j.biomaterials.2020.120417", "ArticleIdList": ["10.1016/j.biomaterials.2020.120417", "32987272"]}, {"Citation": "Kim J., Park H., Saravanakumar G., Kim W. J. (2021). Polymer/aptamer-integrated gold nanoconstruct suppresses the inflammatory process by scavenging ROS and capturing pro-inflammatory cytokine TNF-\u03b1. ACS Appl. Mat. Interfaces 13 (8), 9390\u20139401. 10.1021/acsami.0c15727", "ArticleIdList": ["10.1021/acsami.0c15727", "33155813"]}, {"Citation": "Kouhpayeh S., Hejazi Z., Boshtam M., Mirian M., Rahimmanesh I., Darzi L., et al. (2019). Development of \u03b14 integrin DNA aptamer as a potential therapeutic tool for multiple sclerosis. J Cell. Biochem. 120 (9), 16264\u201316272. 10.1002/jcb.28907", "ArticleIdList": ["10.1002/jcb.28907", "31111537"]}, {"Citation": "Kuang L., Ma X., Ma Y., Yao Y., Tariq M., Yuan Y., et al. (2019). Self-assembled injectable nanocomposite hydrogels coordinated by in situ generated CaP nanoparticles for bone regeneration. ACS Appl. Mat. Interfaces 11 (19), 17234\u201317246. 10.1021/acsami.9b03173", "ArticleIdList": ["10.1021/acsami.9b03173", "31008576"]}, {"Citation": "Laghmouchi A., Hoogstraten C., Falkenburg J., Jedema I. (2020). Long-term in vitro persistence of magnetic properties after magnetic bead-based cell separation of T cells. Scand. J. Immunol. 92 (3), e12924. 10.1111/sji.12924", "ArticleIdList": ["10.1111/sji.12924", "PMC7507180", "32602962"]}, {"Citation": "Lai W. Y., Wang J. W., Huang B. T., Lin E. P.-Y., Yang P.-C. (2019). A novel TNF-\u03b1-targeting aptamer for TNF-\u03b1-mediated acute lung injury and acute liver failure. Theranostics 9 (6), 1741\u20131751. 10.7150/thno.30972", "ArticleIdList": ["10.7150/thno.30972", "PMC6485186", "31037135"]}, {"Citation": "Li S., Jiang D., Rosenkrans Z. T., Barnhart T. E., Ehlerding E. B., Ni D., et al. (2019). Aptamer-conjugated framework nucleic acids for the repair of cerebral ischemia-reperfusion injury. Nano Lett. 19 (10), 7334\u20137341. 10.1021/acs.nanolett.9b02958", "ArticleIdList": ["10.1021/acs.nanolett.9b02958", "PMC6876547", "31518140"]}, {"Citation": "Lin N., Wu L., Xu X., Wu Q., Wang Y., Shen H., et al. (2021). Aptamer generated by cell-SELEX for specific targeting of human glioma cells. ACS Appl. Mat. Interfaces 13 (8), 9306\u20139315. 10.1021/acsami.0c11878", "ArticleIdList": ["10.1021/acsami.0c11878", "33030015"]}, {"Citation": "Lu T., Zhang H., Zhou J., Ma Q., Yan W., Zhao L., et al. (2021). Aptamer-targeting of Aleutian mink disease virus (AMDV) can be an effective strategy to inhibit virus replication. Sci. Rep. 11 (1), 4649. 10.1038/s41598-021-84223-8", "ArticleIdList": ["10.1038/s41598-021-84223-8", "PMC7907208", "33633317"]}, {"Citation": "Ma W., Yang Y., Zhu J. (2022). Biomimetic nanoerythrosome-coated aptamer-DNA tetrahedron/maytansine conjugates: pH-responsive and targeted cytotoxicity for HER2-positive breast cancer[J]. Adv. Mater 2022, e2109609.", "ArticleIdList": ["35064993"]}, {"Citation": "Mandal M., Dutta N., Dutta G. (2021). Aptamer-based biosensors and their implications in COVID-19 diagnosis. Anal. Methods 13 (45), 5400\u20135417. 10.1039/d1ay01519b", "ArticleIdList": ["10.1039/d1ay01519b", "34751684"]}, {"Citation": "Manohar S. M., Shah P., Nair A. (2021). Flow cytometry: Principles, applications and recent advances. Bioanalysis 13 (3), 181\u2013198. 10.4155/bio-2020-0267", "ArticleIdList": ["10.4155/bio-2020-0267", "33543666"]}, {"Citation": "Matai I., Kaur G., Seyedsalehi A., McClinton A., Laurencin C. T. (2020). Progress in 3D bioprinting technology for tissue/organ regenerative engineering. Biomaterials 226, 119536. 10.1016/j.biomaterials.2019.119536", "ArticleIdList": ["10.1016/j.biomaterials.2019.119536", "31648135"]}, {"Citation": "Mitoma H., Horiuchi T., Tsukamoto H., Ueda N. (2018). Molecular mechanisms of action of anti-TNF-\u03b1 agents - comparison among therapeutic TNF-\u03b1 antagonists. Cytokine 101, 56\u201363. 10.1016/j.cyto.2016.08.014", "ArticleIdList": ["10.1016/j.cyto.2016.08.014", "27567553"]}, {"Citation": "Mitroulis I., Alexaki V. I., Kourtzelis I., Ziogas A., Hajishengallis G., Chavakis T. (2015). Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol. Ther. 147, 123\u2013135. 10.1016/j.pharmthera.2014.11.008", "ArticleIdList": ["10.1016/j.pharmthera.2014.11.008", "PMC4324083", "25448040"]}, {"Citation": "Mor-Vaknin N., Saha A., Legendre M., Carmona-Rivera C., Amin M. A., Rabquer B. J., et al. (2017). DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis. Nat. Commun. 8, 14252. 10.1038/ncomms14252", "ArticleIdList": ["10.1038/ncomms14252", "PMC5303823", "28165452"]}, {"Citation": "Nam K., Im B. I., Kim T., Kim Y. M., Roh Y. H. (2021). Anisotropically functionalized aptamer-DNA nanostructures for enhanced cell proliferation and target-specific adhesion in 3D cell cultures. Biomacromolecules 22 (7), 3138\u20133147. 10.1021/acs.biomac.1c00619", "ArticleIdList": ["10.1021/acs.biomac.1c00619", "34111930"]}, {"Citation": "Nastasijevic B., Wright B. R., Smestad J., Warrington A. E., Rodriguez M., Maher L. J. (2012). Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis. PLoS One 7 (6), e39595. 10.1371/journal.pone.0039595", "ArticleIdList": ["10.1371/journal.pone.0039595", "PMC3384608", "22761835"]}, {"Citation": "Ni D., Wei H., Chen W., Bao Q., Rosenkrans Z. T., Barnhart T. E., et al. (2019). Ceria nanoparticles meet hepatic ischemia-reperfusion injury: The perfect imperfection. Adv. Mater 31 (40), e1902956. 10.1002/adma.201902956", "ArticleIdList": ["10.1002/adma.201902956", "PMC6773480", "31418951"]}, {"Citation": "Ni S., Zhuo Z., Pan Y., Yu Y., Li F., Liu J., et al. (2021). Recent progress in aptamer discoveries and modifications for therapeutic applications. ACS Appl. Mat. Interfaces 13 (8), 9500\u20139519. 10.1021/acsami.0c05750", "ArticleIdList": ["10.1021/acsami.0c05750", "32603135"]}, {"Citation": "Orava E. W., Jarvik N., Shek Y. L., Sidhu S. S., Gari\u00e9py J. (2013). A short DNA aptamer that recognizes TNF\u03b1 and blocks its activity in vitro . ACS Chem. Biol. 8 (1), 170\u2013178. 10.1021/cb3003557", "ArticleIdList": ["10.1021/cb3003557", "23046187"]}, {"Citation": "Perschbacher K., Smestad J. A., Peters J. P., Standiford M. M., Denic A., Wootla B., et al. (2015). Quantitative PCR analysis of DNA aptamer pharmacokinetics in mice. Nucleic Acid. Ther. 25 (1), 11\u201319. 10.1089/nat.2014.0515", "ArticleIdList": ["10.1089/nat.2014.0515", "PMC4296750", "25536292"]}, {"Citation": "Perwein M. K., Smestad J. A., Warrington A. E., Heider R. M., Kaczor M. W., Maher L. J., et al. (2018). A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: Where are we now and what comes next? Expert Opin. Biol. Ther. 18 (5), 545\u2013560. 10.1080/14712598.2018.1441284", "ArticleIdList": ["10.1080/14712598.2018.1441284", "29460650"]}, {"Citation": "Plach M., Schubert T. (2020). Biophysical characterization of aptamer-target interactions. Adv. Biochem. Eng. Biotechnol. 174, 1\u201315. 10.1007/10_2019_103", "ArticleIdList": ["10.1007/10_2019_103", "31375847"]}, {"Citation": "Ramaswamy V., Monsalve A., Sautina L., Segal M. S., Dobson J., Allen J. B. (2015). DNA aptamer assembly as a vascular endothelial growth factor receptor agonist. Nucleic Acid. Ther. 25 (5), 227\u2013234. 10.1089/nat.2014.0519", "ArticleIdList": ["10.1089/nat.2014.0519", "PMC4576944", "26125598"]}, {"Citation": "Ren X., Zhao Y., Xue F., Zheng Y., Huang H., Wang W., et al. (2019). Exosomal DNA aptamer targeting \u03b1-synuclein aggregates reduced neuropathological deficits in a mouse Parkinson's disease model. Mol. Ther. - Nucleic Acids 17, 726\u2013740. 10.1016/j.omtn.2019.07.008", "ArticleIdList": ["10.1016/j.omtn.2019.07.008", "PMC6709346", "31437653"]}, {"Citation": "Riccardi C., Napolitano E., Platella C., Musumeci D., Melone M. A. B., Montesarchio D. (2021). Anti\u2010VEGF DNA\u2010based aptamers in cancer therapeutics and diagnostics. Med. Res. Rev. 41 (1), 464\u2013506. 10.1002/med.21737", "ArticleIdList": ["10.1002/med.21737", "33038031"]}, {"Citation": "Roshanbinfar K., Esser T. U., Engel F. B. (2021). Stem cells and their cardiac derivatives for cardiac tissue engineering and regenerative medicine. Antioxidants Redox Signal. 35 (3), 143\u2013162. 10.1089/ars.2020.8193", "ArticleIdList": ["10.1089/ars.2020.8193", "32993354"]}, {"Citation": "Roy T., James B. D., Allen J. B. (2021). Anti-VEGF-R2 aptamer and RGD peptide synergize in a bifunctional hydrogel for enhanced angiogenic potential. Macromol. Biosci. 21 (2), e2000337. 10.1002/mabi.202000337", "ArticleIdList": ["10.1002/mabi.202000337", "PMC7880904", "33191671"]}, {"Citation": "Saito S. (2021). SELEX-based DNA aptamer selection: A perspective from the advancement of separation techniques. Anal. Sci. 37 (1), 17\u201326. 10.2116/analsci.20sar18", "ArticleIdList": ["10.2116/analsci.20sar18", "33132238"]}, {"Citation": "Sarkar A., Saha S., Paul A., Maji A., Roy P., Maity T. K. (2021). Understanding stem cells and its pivotal role in regenerative medicine. Life Sci. 273, 119270. 10.1016/j.lfs.2021.119270", "ArticleIdList": ["10.1016/j.lfs.2021.119270", "33640402"]}, {"Citation": "Sch\u00e4fer R., Wiskirchen J., Guo K., Neumann B., Kehlbach R., Pintaske J., et al. (2007). Aptamer-based isolation and subsequent imaging of mesenchymal stem cells in ischemic myocard by magnetic resonance imaging. Fortschr R\u00f6ntgenstr 179 (10), 1009\u20131015. 10.1055/s-2007-963409", "ArticleIdList": ["10.1055/s-2007-963409", "17879173"]}, {"Citation": "Shahnawaz M., Mukherjee A., Pritzkow S., Mendez N., Rabadia P., Liu X., et al. (2020). Discriminating \u03b1-synuclein strains in Parkinson's disease and multiple system atrophy. Nature 578 (7794), 273\u2013277. 10.1038/s41586-020-1984-7", "ArticleIdList": ["10.1038/s41586-020-1984-7", "PMC7066875", "32025029"]}, {"Citation": "Smestad J., Maher L. R. (2013). Ion-dependent conformational switching by a DNA aptamer that induces remyelination in a mouse model of multiple sclerosis. Nucleic Acids Res. 41 (2), 1329\u20131342. 10.1093/nar/gks1093", "ArticleIdList": ["10.1093/nar/gks1093", "PMC3553947", "23175609"]}, {"Citation": "Son J., Kim J., Lee K., Hwang J., Choi Y., Seo Y., et al. (2019). DNA aptamer immobilized hydroxyapatite for enhancing angiogenesis and bone regeneration. Acta Biomater. 99, 469\u2013478. 10.1016/j.actbio.2019.08.047", "ArticleIdList": ["10.1016/j.actbio.2019.08.047", "31494292"]}, {"Citation": "Strahm Y., Flueckiger A., Billinger M., Meier P., Mettler D., Weisser S., et al. (2010). Endothelial-cell-binding aptamer for coating of intracoronary stents. J. Invasive Cardiol. 22 (10), 481\u2013487.", "ArticleIdList": ["20944188"]}, {"Citation": "Sun T., Meng C., Ding Q., Yu K., Zhang X., Zhang W., et al. (2021). In situ bone regeneration with sequential delivery of aptamer and BMP2 from an ECM-based scaffold fabricated by cryogenic free-form extrusion. Bioact. Mater. 6 (11), 4163\u20134175. 10.1016/j.bioactmat.2021.04.013", "ArticleIdList": ["10.1016/j.bioactmat.2021.04.013", "PMC8099605", "33997500"]}, {"Citation": "Tang W. (2019). Challenges and advances in stem cell therapy. Bst 13 (4), 286. 10.5582/bst.2019.01241", "ArticleIdList": ["10.5582/bst.2019.01241", "31527325"]}, {"Citation": "Tseng W. Y., Huang Y. S., Lin H. H., Luo S.-F., McCann F., McNamee K., et al. (2018). TNFR signalling and its clinical implications. Cytokine 101, 19\u201325. 10.1016/j.cyto.2016.08.027", "ArticleIdList": ["10.1016/j.cyto.2016.08.027", "33730773"]}, {"Citation": "Ueki R., Atsuta S., Ueki A., Hoshiyama J., Li J., Hayashi Y., et al. (2019). DNA aptamer assemblies as fibroblast growth factor mimics and their application in stem cell culture. Chem. Commun. 55 (18), 2672\u20132675. 10.1039/c8cc08080a", "ArticleIdList": ["10.1039/c8cc08080a", "30746545"]}, {"Citation": "Ueki R., Uchida S., Kanda N., Yamada N., Ueki A., Akiyama M., et al. (2020). A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application. Sci. Adv. 6 (14), eaay2801. 10.1126/sciadv.aay2801", "ArticleIdList": ["10.1126/sciadv.aay2801", "PMC7112757", "32270033"]}, {"Citation": "Ueki R., Ueki A., Kanda N., Sando S. (2016). Oligonucleotide\u2010based mimetics of hepatocyte growth factor. Angew. Chem. Int. Ed. 55 (2), 579\u2013582. 10.1002/anie.201508572", "ArticleIdList": ["10.1002/anie.201508572", "26592704"]}, {"Citation": "Valera E., Masliah E. (2016). Combination therapies: The next logical Step for the treatment of synucleinopathies? Mov. Disord. 31 (2), 225\u2013234. 10.1002/mds.26428", "ArticleIdList": ["10.1002/mds.26428", "PMC4747680", "26388203"]}, {"Citation": "Wang M., Wu H., Li Q., Yang Y., Che F., Wang G., et al. (2019). Novel aptamer-functionalized nanoparticles enhances bone defect repair by improving stem cell recruitment. Ijn 14, 8707\u20138724. 10.2147/ijn.s223164", "ArticleIdList": ["10.2147/ijn.s223164", "PMC6847998", "31806966"]}, {"Citation": "Wang X., Song X., Li T., Chen J., Cheng G., Yang L., et al. (2019). Aptamer-functionalized bioscaffold enhances cartilage repair by improving stem cell recruitment in osteochondral defects of rabbit knees. Am. J. Sports Med. 47 (10), 2316\u20132326. 10.1177/0363546519856355", "ArticleIdList": ["10.1177/0363546519856355", "31233332"]}, {"Citation": "Wang X., Zheng X., Duan Y., Ma L., Gao C. (2019). Defined substrate by aptamer modification with the balanced properties of selective capture and stemness maintenance of mesenchymal stem cells. ACS Appl. Mat. Interfaces 11 (16), 15170\u201315180. 10.1021/acsami.9b03333", "ArticleIdList": ["10.1021/acsami.9b03333", "30942571"]}, {"Citation": "Wang Y., Khaing Z. Z., Li N., Hall B., Schmidt C. E., Ellington A. D. (2010). Aptamer antagonists of myelin-derived inhibitors promote axon growth. PLoS One 5 (3), e9726. 10.1371/journal.pone.0009726", "ArticleIdList": ["10.1371/journal.pone.0009726", "PMC2838799", "20300533"]}, {"Citation": "Wilbanks B., Smestad J., Heider R. M., Warrington A. E., Rodriguez M., Maher L. J. (2019). Optimization of a 40-mer antimyelin DNA aptamer identifies a 20-mer with enhanced properties for potential multiple sclerosis therapy. Nucleic Acid. Ther. 29 (3), 126\u2013135. 10.1089/nat.2018.0776", "ArticleIdList": ["10.1089/nat.2018.0776", "PMC6555174", "30855209"]}, {"Citation": "Wood A., Vassallo A., Summers C., Chilvers E. R., Conway-Morris A. (2018). C5a anaphylatoxin and its role in critical illness-induced organ dysfunction. Eur. J. Clin. Invest. 48 (12), e13028. 10.1111/eci.13028", "ArticleIdList": ["10.1111/eci.13028", "30229880"]}, {"Citation": "Wu J., Liyarita B. R., Zhu H., Liu M., Hu X., Shao F. (2021). Self-assembly of dendritic DNA into a hydrogel: Application in three-dimensional cell culture. ACS Appl. Mat. Interfaces 13 (42), 49705\u201349712. 10.1021/acsami.1c14445", "ArticleIdList": ["10.1021/acsami.1c14445", "34658242"]}, {"Citation": "Yamanaka S. (2020). Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 27 (4), 523\u2013531. 10.1016/j.stem.2020.09.014", "ArticleIdList": ["10.1016/j.stem.2020.09.014", "33007237"]}, {"Citation": "Yang M., Chen X., Zhu L., Lin S., Li C., Li X., et al. (2021). Aptamer-functionalized DNA-silver nanocluster nanofilm for visual detection and elimination of bacteria. ACS Appl. Mat. Interfaces 13 (32), 38647\u201338655. 10.1021/acsami.1c05751", "ArticleIdList": ["10.1021/acsami.1c05751", "34347427"]}, {"Citation": "Yang Z., Zhao T., Gao C., Cao F., Li H., Liao Z., et al. (2021). 3D-Bioprinted difunctional scaffold for in situ cartilage regeneration based on aptamer-directed cell recruitment and growth factor-enhanced cell chondrogenesis. ACS Appl. Mat. Interfaces 13 (20), 23369\u201323383. 10.1021/acsami.1c01844", "ArticleIdList": ["10.1021/acsami.1c01844", "33979130"]}, {"Citation": "Yao C., Tang H., Wu W., Tang J., Guo W., Luo D., et al. (2020). Double rolling circle amplification generates physically cross-linked DNA network for stem cell fishing. J. Am. Chem. Soc. 142 (7), 3422\u20133429. 10.1021/jacs.9b11001", "ArticleIdList": ["10.1021/jacs.9b11001", "31893497"]}, {"Citation": "Yatime L., Maasch C., Hoehlig K., Klussmann S., Andersen G. R., Vater A. (2015). Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer. Nat. Commun. 6, 6481. 10.1038/ncomms7481", "ArticleIdList": ["10.1038/ncomms7481", "PMC4423239", "25901944"]}, {"Citation": "Yoon J. W., Jang I. H., Heo S. C., Kwon Y. W., Choi E. J., Bae K. H., et al. (2015). Isolation of foreign material-free endothelial progenitor cells using CD31 aptamer and therapeutic application for ischemic injury. PLoS One 10 (7), e0131785. 10.1371/journal.pone.0131785", "ArticleIdList": ["10.1371/journal.pone.0131785", "PMC4493074", "26148001"]}, {"Citation": "Zhang N., Wang Z., Zhao Y. (2020). Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases. Cytokine & Growth Factor Rev. 55, 80\u201385. 10.1016/j.cytogfr.2020.03.002", "ArticleIdList": ["10.1016/j.cytogfr.2020.03.002", "32327345"]}, {"Citation": "Zhang T., Tian T., Lin Y. (2021). Functionalizing framework nucleic-acid-based nanostructures for biomedical application[J]. Adv. Mater 2021, e2107820.", "ArticleIdList": ["34787933"]}, {"Citation": "Zhang X., Hu J., Becker K. V., Engle J. W., Ni D., Cai W., et al. (2021). Antioxidant and C5a-blocking strategy for hepatic ischemia-reperfusion injury repair. J. Nanobiotechnol 19 (1), 107. 10.1186/s12951-021-00858-9", "ArticleIdList": ["10.1186/s12951-021-00858-9", "PMC8050892", "33858424"]}, {"Citation": "Zhang X., Liu N., Zhou M., Li S., Cai X. (2021). The application of tetrahedral framework nucleic acids as a drug carrier in biomedicine fields. Cscr 16 (1), 48\u201356. 10.2174/1574888x15666200422103415", "ArticleIdList": ["10.2174/1574888x15666200422103415", "32321408"]}, {"Citation": "Zhang Z., Pandey R., Li J., Gu J., White D., Stacey H. D., et al. (2021). High\u2010affinity dimeric aptamers enable the rapid electrochemical detection of wild\u2010type and B.1.1.7 SARS\u2010CoV\u20102 in unprocessed saliva. Angew. Chem. Intl Ed. 60 (45), 24266\u201324274. 10.1002/anie.202110819", "ArticleIdList": ["10.1002/anie.202110819", "PMC8596624", "34464491"]}, {"Citation": "Zhao N., Coyne J., Xu M., Zhang X., Suzuki A., Shi P., et al. (2019). Assembly of bifunctional aptamer-fibrinogen macromer for VEGF delivery and skin wound healing. Chem. Mat. 31 (3), 1006\u20131015. 10.1021/acs.chemmater.8b04486", "ArticleIdList": ["10.1021/acs.chemmater.8b04486", "PMC6761992", "31558852"]}, {"Citation": "Zheng Y., Qu J., Xue F., Zheng Y., Yang B., Chang Y., et al. (2018). Novel DNA aptamers for Parkinson's disease treatment inhibit \u03b1-synuclein aggregation and facilitate its degradation. Mol. Ther. - Nucleic Acids 11, 228\u2013242. 10.1016/j.omtn.2018.02.011", "ArticleIdList": ["10.1016/j.omtn.2018.02.011", "PMC5992446", "29858057"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "6", "Day": "23"}, {"Year": "2022", "Month": "8", "Day": "8"}, {"Year": "2022", "Month": "9", "Day": "15", "Hour": "2", "Minute": "25"}, {"Year": "2022", "Month": "9", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "16", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["36105606", "PMC9465253", "10.3389/fbioe.2022.976960", "976960"]}}], "PubmedBookArticle": []}